# HMH Holding Inc: financial statements, quarterly

HMH · Nasdaq · CIK 2021880 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hmh.md) · [Financials](/companies/hmh/financials.md) · [Filings](/companies/hmh/filings.md) · [Insiders](/companies/hmh/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hmh/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | [203](/filings/0001628280-26-053385.md) | not reported | [171](/filings/0001628280-26-053385.md) |
| Cost of revenue | $m | not reported | [152](/filings/0001628280-26-053385.md) | not reported | [110](/filings/0001628280-26-053385.md) |
| Research and development | $m | not reported | [0.6](/filings/0001628280-26-053385.md) | not reported | [0.8](/filings/0001628280-26-053385.md) |
| Selling, general and administrative | $m | not reported | [29.4](/filings/0001628280-26-053385.md) | not reported | [60.4](/filings/0001628280-26-053385.md) |
| Operating income | $m | not reported | [20.8](/filings/0001628280-26-053385.md) | not reported | [(4.8)](/filings/0001628280-26-053385.md) |
| Interest expense | $m | not reported | [9.1](/filings/0001628280-26-053385.md) | not reported | [3.9](/filings/0001628280-26-053385.md) |
| Income tax | $m | not reported | [5.2](/filings/0001628280-26-053385.md) | not reported | [(4.5)](/filings/0001628280-26-053385.md) |
| Net income | $m | not reported | [8.9](/filings/0001628280-26-053385.md) | [3.9](/filings/0001628280-26-053385.md) | [5.0](/filings/0001628280-26-053385.md) |
| Diluted EPS | $ per share | [30560.00](/filings/0001628280-26-031295.md) | [0.13](/filings/0001628280-26-053385.md) | [17240.00](/filings/0001628280-26-031295.md) | [0.42](/filings/0001628280-26-053385.md) |
| Basic EPS | $ per share | [30560.00](/filings/0001628280-26-031295.md) | [0.13](/filings/0001628280-26-053385.md) | [17240.00](/filings/0001628280-26-031295.md) | [0.43](/filings/0001628280-26-053385.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | period not labelled (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | [96.6](/filings/0001628280-26-053385.md) | not reported | [120](/filings/0001628280-26-053385.md) |
| Current assets | $m | not reported | not reported | not reported | [629](/filings/0001628280-26-053385.md) | not reported | [649](/filings/0001628280-26-053385.md) |
| Total assets | $m | not reported | not reported | not reported | [1,358](/filings/0001628280-26-053385.md) | [0.0](/filings/0001628280-26-031295.md) | [1,363](/filings/0001628280-26-053385.md) |
| Current liabilities | $m | not reported | not reported | not reported | [224](/filings/0001628280-26-053385.md) | not reported | [218](/filings/0001628280-26-053385.md) |
| Total liabilities | $m | not reported | not reported | not reported | [657](/filings/0001628280-26-053385.md) | not reported | [516](/filings/0001628280-26-053385.md) |
| Long-term debt | $m | not reported | not reported | not reported | [340](/filings/0001628280-26-053385.md) | not reported | [198](/filings/0001628280-26-053385.md) |
| Current portion of debt | $m | not reported | not reported | not reported | [0.7](/filings/0001628280-26-053385.md) | not reported | [1.5](/filings/0001628280-26-053385.md) |
| Shareholders' equity | $m | [631](/filings/0001628280-26-053385.md) | [651](/filings/0001628280-26-053385.md) | [669](/filings/0001628280-26-053385.md) | [700](/filings/0001628280-26-053385.md) | [710](/filings/0001628280-26-053385.md) | [210](/filings/0001628280-26-053385.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Shares

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [0.0](/filings/0001628280-26-031295.md) | [69.4](/filings/0001628280-26-053385.md) | [0.0](/filings/0001628280-26-031295.md) | [12.0](/filings/0001628280-26-053385.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.